Anavex Life Sciences
AVXL
#9441
Rank
$0.13 B
Marketcap
$1.51
Share price
1.34%
Change (1 day)
-82.48%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -$12.96 Million USD

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$40 Million USD, an increase over its 2024 earnings that were of -$51.56 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$12.96 Million-67.61%
2025 -$40 Million-22.43%
2024 -$51.56 Million14.77%
2023 -$44.93 Million-17.49%
2022 -$54.45 Million22.96%
2021 -$44.28 Million35.36%
2020 -$32.71 Million12.65%
2019 -$29.04 Million29.09%
2018 -$22.5 Million36.33%
2017 -$16.5 Million17.11%
2016 -$14.09 Million20.91%
2015 -$11.66 Million-6.29%
2014 -$12.44 Million337.28%
2013 -$2.85 Million
2008 -$5.26 Million106.01%
2007 -$2.56 Million8848.98%
2006 -$0.03 Million-79.99%
2005 -$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
$0.24 B-1,984.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
$6.4 M-149.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-$6.25 Million-51.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-$0.39 Billion 2,842.85%๐Ÿ‡บ๐Ÿ‡ธ USA